Abstract
Epidemiological studies suggest that men with type 2 diabetes are less likely than non-diabetic men to develop prostate cancer. The cause of this association is not known. Recent genetic studies have highlighted a potential genetic link between the two diseases. Two studies have identified a version (allele) of a variant in the HNF1B (also known as TCF2) gene that predisposes to type 2 diabetes, and one of them showed that the same allele protects men from prostate cancer. Other, separate, studies have identified different variants in the JAZF1 gene, one associated with type 2 diabetes, another associated with prostate cancer. These findings are unlikely to completely explain the epidemiological association between the two diseases but they provide new insight into a possible direct causal link, rather than one that is confounded or biased in some way.
Original language | English |
---|---|
Pages (from-to) | 1757-1760 |
Number of pages | 4 |
Journal | Diabetologia |
Volume | 51 |
Issue number | 10 |
DOIs |
|
Publication status | Published - Oct 2008 |
Keywords
- Epidemiology
- Genes
- Genome-wide association study
- Pleiotropy
- Prostate cancer
- Transcription factors
- Type 2 diabetes
- Genome-wide association
- Metabolic syndrome
- Reduced risk
- US men
- Variants
- Mellitus
- Mutations
- Multiple
- Loci
- Susceptibility